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Abstract
Background: Data from over 4 decades have reported a higher incidence of silent infarction among patients with 
diabetes mellitus (DM), but recent publications have shown conflicting results regarding the correlation between DM 
and presence of pain in patients with acute coronary syndromes (ACS).
Objective: Our primary objective was to analyze the association between DM and precordial pain at hospital arrival. Secondary 
analyses evaluated the association between hyperglycemia and precordial pain at presentation, and the subgroup of patients 
presenting within 6 hours of symptom onset.
Methods: We analyzed a prospectively designed registry of 3,544 patients with ACS admitted to a Coronary Care Unit 
of a tertiary hospital. We developed multivariable models to adjust for potential confounders.
Results: Patients with precordial pain were less likely to have DM (30.3%) than those without pain (34.0%; unadjusted 
p = 0.029), but this difference was not significant after multivariable adjustment, for the global population (p = 0.84), 
and for subset of patients that presented within 6 hours from symptom onset (p = 0.51). In contrast, precordial pain 
was more likely among patients with hyperglycemia (41.2% vs 37.0% without hyperglycemia, p = 0.035) in the overall 
population and also among those who presented within 6 hours (41.6% vs. 32.3%, p = 0.001). Adjusted models showed 
an independent association between hyperglycemia and pain at presentation, especially among patients who presented 
within 6 hours (OR = 1.41, p = 0.008). 
Conclusion: In this non-selected ACS population, there was no correlation between DM and hospital presentation 
without precordial pain. Moreover, hyperglycemia correlated significantly with pain at presentation, especially in the 
population that arrived within 6 hours from symptom onset. (Arq Bras Cardiol. 2014; 103(3):183-191)
Keywords: Diabetes Mellitus; Acute Coronary Syndrome; Chest Pain; Hyperglycemia.
Introduction
Since the 1960’s several investigators have reported a 
correlation between the presence of diabetes mellitus (DM) 
and a higher threshold for ischemic pain1,2. Necropsy data 
demonstrated a higher incidence of lesions at afferent nerves 
that conduct pain3, supporting the hypothesis that patients 
with DM have impaired sensation of precordial pain. However, 
subsequent clinical data have provided conflicting results4-12. 
For example, in analyses of patients undergoing exercise 
stress testing and 48-hour continuous electrocardiographic 
monitoring to evaluate ischemia, Caracciolo et al.5 found 
a similar prevalence of asymptomatic ischemia using both 
modalities in diabetics compared with non-diabetics. 
Meanwhile, Falcone et al6 found an even higher incidence 
of angina during daily activities in patients with DM, while 
others reported a higher prevalence of painless ischemia 
among patients with DM7.
Another method to explore the association between 
DM and symptomatic ischemia is to analyze the rate of 
unrecognized (silent) myocardial infarction in longitudinal 
studies. The majority of the publications report an 
absence of correlation between the presence of DM and 
silent MI, even when taking into account the presence of 
diabetic neuropathy8-11. These findings led Sheffer et al. 
to comment in a review of the topic that, “none of the 
existing epidemiologic analyses have identified diabetes as 
an independent predictor of infarct recognition”12.
Analyses of the presence of chest pain at hospital arrival in 
patients with or without diabetes with acute coronary syndromes 
(ACS) represent a third opportunity to explore this question – 
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results to date have been conflicting13,14. Since hyperglycemia is 
a strong predictor of in-hospital mortality15-18, and admission with 
ACS often represents the unmasking of previously undiagnosed 
DM19, exploration of the association between hyperglycemia 
at presentation and presence or absence of pain with ACS 
represents another venue to explore this issue. 
The main purpose of this study was to analyze the 
associations between prior diabetes and the presence or 
absence of precordial pain in patients presenting at the 
hospital with ACS. The secondary aims included exploring the 
association between hyperglycemia and precordial pain, as well 
as analyzing the same associations in the subgroup of patients 
arriving at the hospital within 6 hours of symptom onset.
Methods
We analyzed data from a cohort of 3544 consecutive 
non-selected patients with ACS (1405 with ST-segment 
elevation myocardial infarction (STEMI), 1425 with 
non-STEMI, and 724 unstable angina) from a prospective 
registry of patients admitted to a coronary care unit of a 
tertiary hospital from 02/1998 to 04/2012. The registry 
included patients whose symptom onset started within 
7 days, and included patients who were transferred from 
another hospital. We have used standard definitions to 
diagnose AMI as described in the concurrent guidelines, 
with measurement of creatine-kinase myocardial band 
(CK-MB) mass and cardiac troponin I on a routine basis 
from 2001 onward.
The presence of precordial pain at hospital arrival was 
determined by review of the patient’s information obtained 
by the admitting physician(s) in the coronary care unit. 
Patient who were unconscious or disoriented were excluded. 
Patients who experienced other symptoms, such as dyspnea, 
fatigue, or other “ischemic equivalents” were classified as 
not having precordial pain. We defined the presence of 
diabetes mellitus from the medical history and/or use of 
glucose lowering drugs. Patients who had newly diagnosed 
diabetes during hospitalization were classified as not having 
diabetes at presentation. We defined hyperglycemia as the 
presence of a blood glucose level of > 125 mg/dL measured 
in the local hospital laboratory on the first measurement after 
hospital arrival.
Statistical analyses
The Chi-square and Fisher exact test were used for the 
comparison between categorical variables as appropriate.   
The Mann-Whitney (non-normal distribution, as determined by the 
Kolmogorov-Smirnov test) or Student’s t-test (normal distribution) 
was used for comparisons between continuous variables.
Model development
Several adjusted models were developed to analyze the 
association between history of diabetes or hyperglycemia 
and presence of absence of pain at hospital arrival, using 
the backward stepwise logistic regression method. Those 
variables were chosen to develop a broad scenario regarding 
patient information at hospital arrival. The first 3 models 
tested the correlation between history of diabetes and pain at 
hospital arrival. Model 1A included as independent variables 
those listed in Table 1, except time from symptom onset 
and hyperglycemia. Model 1B included the same variables, 
plus time from symptom onset (as a continuous variable).   
Finally, model 1C was similar to model 1A, but was restricted 
to the population arriving at the hospital within 6 hours of 
symptom onset. Because history of diabetes was excluded in 
the first steps of the development of models 1A, 1B and 1C, 
similar additional models were developed, forcing the variable 
(history of diabetes) into the model. In order to analyze the 
association between hyperglycemia and pain at hospital arrival, 
we substituted history of diabetes by hyperglycemia in models 
1A, 1B and 1C, generating models 2A, 2B and 2C respectively. 
Because hyperglycemia was excluded in the early steps of model 
2A development, an additional model forcing the variable 
hyperglycemia until the last step was developed.
SPSS version 20.0 software (IBM, USA) was used for the 
analyses and a p-value < 0.05 (2-tailed) was considered statistically 
significant, with no corrections for multiple comparisons.
Results
The characteristics of the population are shown in 
Table 1. The mean age was 64.1 years and 68.6% were men.   
As commonly seen in tertiary hospitals, the incidence of 
risk factors was high, including 31.5% with known diabetes.   
As expected, significant differences were observed between 
the groups with vs. without precordial pain. For example, 
patients in the painless group were older and more likely to 
be smokers; on the other hand, this group had lower rates of 
previous heart failure, hypertension, coronary artery bypass 
graft surgery and were less likely to present with STEMI.
Figure 1 shows the unadjusted associations between 
a history of diabetes and presence of precordial pain at 
hospital arrival in the overall population (diabetes present 
in 30.3% with vs. 34.0% without pain, p = 0.029), as well 
as the subgroup who presented within 6 hours of symptom 
onset (30.2% vs 31.8%, p = 0.51).
There was no significant correlation between the presence 
of pain and in-hospital deaths (overall population: 8.8% for 
the painless group vs. 8.0% for the group with precordial 
pain, p = 0.44; subgroup within 6 hours from symptom 
onset: 7.6% vs. 7.2%, p = 0.74). Meanwhile, there was 
a higher rate of in-hospital mortality among patients with 
history of diabetes (overall population: DM 10.1% vs 7.4% 
for no DM, p = 0.006; subgroup within 6 hours of symptom 
onset 9.5% vs. 6.3%, p = 0.010).
Table 2 shows the variables that independently 
correlated with the presence of pain at hospital arrival in 
models 1A, 1B and 1C. Notably, a history of diabetes was 
not a significant predictor in any of the 3 models, with ORs 
of 0.97 (p = 0.67), 0.98 (p = 0.84) and 1.04 (p = 0.72), 
respectively when forced into models 1A, 1B and 1C. 
Figure 2 depicts the unadjusted and adjusted odds-ratios 
for the correlation between a history of diabetes and the 
presence of pain at hospital arrival.
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Figure 1 – Prevalence of diabetes mellitus according to the presence or absence of pain at hospital arrival. Patients presenting with pain (dark bars) were slightly less 
likely to have diabetes among the overall population, but the same was not true among those who presented within 6 hours of symptom onset. 
Table 1 – Comparison between patients with or without chest pain at hospital arrival
Variable Total Without CP With CP OR (95% CI) p-value
N (%) of patients 3544 (100) 1154 (32.6) 2390 (67.4)
Mean age (SE), y 64.0 (0.21) 65.7 (0.37) 63.3 (0.26) < 0.001
Male gender (%) 68.6 65 70.3 1.28 (1.10-1.48) 0.001
Caucasians (%) 86.3 86.0 86.4 1.03 (0.84-1.26) 0.801
History of Angina (%) 35.5 34.1 36.1 1.09 (0.94-1.26) 0.252
Hypercholesterolemia 56.2 58.0 55.4 0.90 (0.78-1.04) 0.148
Family with CAD 26.7 23.3 28.3  1.30 (1.10-1.53) 0.002
Diabetes 31.5 34.0 30.3 0.85 (0.73-0.98) 0.029
Hypertension 74.5 79.0 72.4 0.70 (0.59-0.82) < 0.001
STEMI (%) 39.7 23.9 47.3 2.87 (2.45-3.35) < 0.001
Mean time - symptom onset to hospital 
arrival (SE), h* 9.2 (0.49) 14.2 (1.15) 7.3 (0.51) 2.11 (1.78-2.49) < 0.001
Symptom onset to hospital arrival ≤ 6h (%) 70.4 22.7 77.3 2.11 (1.78-2.49) < 0.001
Mean glucose level at hospital 
arrival (SE), mg/dL**
137.87 (1.30) 135.9 (2.2) 139.2 (1.6) 1.19 (1.01-1.40) 0.072
Hyperglycemia (%) 39.9 37.0 41.2 1.19 (1.01-1.40) 0.035
Prior PCI (%) 21 22.2 20.4 0.90 (0.76-1.06) 0.218
Prior CABG (%) 18.1 21.8 16.4 0.70 (0.59-0.84) < 0.001
Prior AMI (%) 32.5 33.0 32.3 0.97 (0.83-1.12) 0.652
Prior Stroke (%) 4.9 4.4 5.1 1.17 (0.84-1.64) 0.348
Prior Heart failure (%) 9.0 12.7 8.7 0.65 (0.53-0.65) < 0.001
Current smoker (%) 23.7 19.4 25.7 1.44 (1.21-1.71) < 0.001
(*)N = 3040; (**)N = 2867
CP: Chest Pain; OR: Odds-Ratio; CI: Confidence Interval; CAD: Coronary Artery Disease; STEMI- ST: elevation myocardial infarction; PCI: Percutaneous Coronary 
Intervention; CABG: Coronary Artery Bypass Graft; AMI: Acute Myocardial Infarction.
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Table 2 – Variables that were significantly and independently correlated with presence of chest pain at hospital arrival*
Variable Adj. OR. (95% CI) p-value
STEMI 2.91 (2.46-3.43) < 0.001
History of angina 1.33 (1.14-1.56) 0.001
Age (per year) 0.99 (0.98-1.00) 0.004
Previous myocardial infarction  1.21 (1.03-1.43) 0.019
History of heart failure 0.77 (0.60-0.98) 0.032
History of arterial hypertension 0.83 (0.69-0.99) 0.038
Variable Adj. OR (95% CI) p-value
STEMI 2.76 (2.28-3.34) < 0.001
Time from symptom onset < 6h 1.89 (1.59-2.25) < 0.001
History of angina 1.42 (1.19-1.70) <0.001
Previous myocardial infarction  1.33 (1.09-1.62) 0.004
Age (per year) 0.99 (0.98-1.00) 0.033
Variable OR adj. (95% CI) p-value
STEMI 3.07(2.43-3.87) < 0.001
History of angina 1.37 (1.09-1.71) 0.006
Age (per year) 0.99 (0.98-1.00) 0.017
A- Included the baseline variables except time from symptom onset (see text); B- Adding time from symptom onset; C- Subgroup with time from symptom onset ≤ 6h; 
adj OR:- adjusted Odds-Ratio; CI: confidence interval; STEMI: ST-elevation myocardial infarction.
Figure 2 – Correlation between history of diabetes and presence of pain at hospital arrival. In adjusted models, the presence of diabetes was not associated with the 
presence of pain at hospital presentation in either the overall population, or among the subgroup who presented within 6 hours of symptom onset.
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There was a significant correlation (unadjusted) between 
hyperglycemia at presentation and the presence of precordial 
pain at hospital arrival in the overall population and also in the 
subgroup that arrived in the hospital within 6 hours of symptom 
onset (Figure 3). Moreover, hyperglycemia was associated with 
a significantly higher rate of in-hospital mortality: 13.9% vs. 
5.0% for patients with vs. without hyperglycemia (OR = 3.07, 
p < 0.001) for the overall population and 12.9% vs. 4.1% 
(OR = 3.43, p < 0.001) for those within 6 hours of symptom 
onset. Finally, hyperglycemia was significantly associated with 
STEMI (OR = 1.53, p < 0.001), presence of precordial pain at 
hospital arrival (OR = 1.49, p = 0.001) and history of diabetes 
(OR = 7.44, p < 0.001).
In the three adjusted models (Table 3), there was a 
positive correlation between hyperglycemia and presence 
of precordial pain in models 2B and 2C, but not in 2A, 
where the OR for hyperglycemia was 1.14 (p = 0.14). 
Figure 4 shows the unadjusted and adjusted odds-ratios 
for the association between hyperglycemia and presence 
of precordial pain at hospital arrival. Overall, considering 
all 6 models developed, the variables that best correlated 
with the presence of precordial pain at hospital arrival were 
presentation with STEMI and previous angina (significant 
correlation in all the 6 models), while older age and prior 
MI were significant correlated with precordial pain in 5 out 
of the 6 models.
Discussion
We showed in this analysis of 3544 consecutive and 
unselected patients with ACS admitted to the coronary care 
unit of a tertiary hospital that:
(1) A history of DM was not independently associated with 
precordial pain at hospital arrival in any of the adjusted models;
(2) The presence of hyperglycemia was independently 
correlated with precordial pain in 2 of the 3 adjusted models; 
(3) Presentation with STEMI and a prior history of angina 
were most strongly associated with presentation with 
precordial pain at hospital arrival.
Potential causes of blunted perception of ACS in patients 
with DM include receptor and afferent neuron dysfunction, 
gating mechanisms and neuropsychiatric factors. While 
autonomic neuropathy has been proposed by some as the 
possible explanation for the relatively high incidence of painless 
ischemia in diabetic patients3, others have failed to demonstrate 
cardiac denervation in patients with DM20. As noted by Sheifer 
et al12, diabetic neuropathy may impair recognition of pain, 
but significant neurological dysfunction typically appears only 
in patients with advanced disease.
In 1973, Margolis et a8 published their classic paper, 
showing that out of 259 patients with electrocardiographically 
documented MI, 23% were discovered only by routine ECG 
at the time of the patient’s bi-annual routine examination. 
Moreover, they showed that unrecognized MI is rare in 
patients with prior angina pectoris and despite a numerically 
higher incidence in patients with diabetes or hypertension, 
the difference did not reach statistical significance8. In 1995 
Sigurdsson et al10 obtained similar results: at least one third 
of all MI were unrecognized, there was a strong correlation 
between absence of angina and unrecognized MI and risk 
factor profiles were similar in recognized or unrecognized 
MI. In a recently published review, the prevalence of silent 
MI in the general population varied from 22% to 64% and 
from 29% to 79% in diabetic patients11.
Specifically among patients with acute myocardial 
infarction, 33% of patients did not have precordial pain in 
a North-American registry (National Registry of Myocardial 
Infarction 2)13, while the incidence was much lower (10%) 
in a report from South Korea21. However, it is noteworthy 
that this difference could be explained, at least in part, 
by the fact that the South Korean registry included only 
patients with STEMI undergoing primary PCI, whereas 
the North-American registry included an unselected 
population of AMI patients. The present study was more 
similar to the North-American registry in that we analyzed 
data from an unselected population, and indeed found 
a similar percentage of patients who did not experience 
precordial pain (32.7%).
 We did not find a strong correlation between the absence 
of precordial pain and diabetes in our registry of patients with 
ACS. Similar findings were first described by Christensen et 
al in 198522 in a population of patients with AMI, and were 
subsequently replicated in recent registries14. However, the 
aforementioned North-American registry did find a significant 
and independent association between the absence of 
precordial pain and presence of diabetes (adjusted OR 1.21, 
95% CI 1.19-1.23)13, contrary to the findings in our study and 
the others described above. Importantly, the North American 
registry did not adjust for STEMI as a potential confounder, 
despite the strong correlation between the presence of 
precordial pain and presentation with STEMI.
To the best of our knowledge, our analysis is one of 
the first to report the association between hyperglycemia 
at presentation and the presence of precordial pain. We 
found a positive correlation, especially for patients arriving 
to the hospital within 6 hours from symptom onset.   
One possible explanation for the finding could be related to 
the highly significant correlation between hyperglycemia at 
presentation and STEMI, the most acute of all manifestations 
of coronary artery disease.
We recognize several limitations to our analyses. First, 
although the registry sample was prospectively collected, 
the present analyses were retrospective and, therefore, they 
have the limitations of this type of clinical investigation. 
Secondly, only one question regarding the presence or 
absence of precordial pain at hospital arrival was ascertained 
in the dataset, with no information obtained regarding 
other symptoms such as dyspnea, nausea, syncope, fatigue 
or regarding the characteristics of the pain. Thirdly, we did 
not collect information on the type of diabetic therapy; 
however, it is important to note that Kentsch et al14 did not 
find any correlation between the use of insulin and presence 
of angina. Lastly, we cannot exclude the possibility of bias 
in the selection of patients included in this registry, as one 
might expect a higher rate of hospitalization for patients who 
experience precordial pain compared with those without pain.
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Figure 3 – Incidence of hyperglycemia according to the presence or absence of pain at hospital arrival. Patients with hyperglycemia (dark bars), defined as first glucose 
level >125 mg/dL after hospital arrival, were more likely to present with pain compared with those without hyperglycemia in the overall population and also among those 
with symptom onset within 6 hours.
Table 3 – Variables that were significantly and independently correlated with presence of chest pain at hospital arrival, substituting history of 
diabetes by glucose level at hospital arrival
Variable OR adj. (95% CI) p-value
STEMI 2.74 (2.28-3.30) < 0.001
History of angina 1.33 (1.12-1.59) 0.001
History of stroke 1.85 (1.22-2.80) 0.004
Previous myocardial infarction 1.27 (1.06-1.53) 0.010
History of heart failure 0.71 (0.55-0.93) 0.014
Male gender 1.22 (1.02-1.45) 0.029
Family with CAD 1.23 (1.01-1.49) 0.034
Age (per year) 0.99 (0.97-1.00) 0.050
Variable Adj. OR (95% CI) p-value
STEMI 2.60 (2.10-3.21) < 0.001
Time from symptom onset < 6h 1.99 (1.64-2.42) < 0.001
History of angina 1.42 (1.16-1.74) 0.001
Previous myocardial infarction 1.37 (1.11-2.92) 0.004
History of heart failure 0.67 (0.49-0.91) 0.011
Previous stroke 1.81 (1.12-2.92) 0.015
Age (per year) 0.99 (0.98-1.00) 0.033
Variable Adj. OR(95% CI) p-value
STEMI 2.99 (2.30-3.89) < 0.001
Previous myocardial infarction 1.52 (1.16-1.97) 0.003
History of stroke 2.33 (1.13-4.78) 0.022
History of angina 1.30 (1.01-1.67) 0.044
Smoking 1.35 (1.01-1.80) 0.045
Included the baseline variables except time from symptom onset (see text); B- Adding time from symptoms onset; C- Subgroup with time from symptoms onset ≤ 6h; adj 
OR: adjusted Odds-Ratio; CI: confidence interval; STEMI: ST-elevation myocardial infarction.
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Figure 4 – Correlation between hyperglycemia and presence of pain at hospital arrival. In adjusted models, patients with hyperglycemia were not more likely to present 
with pain in the total population. However, among those who had symptom onset within 6 hours, there was a 41% increase in the odds of presenting with pain compared 
with those without hyperglycemia after multivariable adjustment. 
Conclusion
The present study suggests that, contrary to what has 
been deemed “common knowledge” for several decades, 
the presence of diabetes did not correlate independently 
with a higher likelihood of absence of precordial pain in this 
registry of patients presenting with ACS at a tertiary medical 
center. In addition, we found that acute-phase hyperglycemia 
is more common in patients presenting with precordial pain, 
particularly when they present within 6 hours from symptom 
onset. Patients with STEMI and those who have a prior history 
of angina are more likely to present with precordial pain at 
the time of presentation with AMI.
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